MiniMed Group Inc. (MMED) is a Medical/Dental Instruments company listed on NASDAQ. In the last 30 days Quantisnow tracked 28 wire items for MMED, including 14 insider trades, 8 press releases and news items and 2 analyst ratings. The most recent was published Nov 6, 2026.
MMED rankings
Financial highlights
Full financials- Revenue, TTM
- $3.22B
- Net income, TTM
- -$309.00M
- Net margin
- -9.6%
- Cash
- $207.00M
For the twelve months ended Jul 31, 2026, from SEC filings. Not investment advice.
News · 26 weeks84-70%
2026-05-172026-11-08
Mix5490d
- SEC Filings16(30%)
- Insider16(30%)
- Other15(28%)
- Analyst4(7%)
- Leadership2(4%)
- Earnings1(2%)
Activity · 52 weeks12653 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- 13D/GSEC Form SCHEDULE 13G filed by MiniMed Group Inc.SCHEDULE 13G - MiniMed Group, Inc. (0002062583) (Subject)
- PRMiniMed to Participate in Upcoming Investor ConferencesNORTHRIDGE, Calif., Nov. 5, 2026 /PRNewswire/ -- MiniMed (NASDAQ:MMED), a global leader in diabetes technology, today announced that Chad Spooner, EVP, Chief Financial Officer, will discuss and answer questions on the company at the following investor conferences: 9th Annual Evercore Healthcare Conference Tuesday, December 1, 2026, at 10:50 a.m. EST / 7:50 a.m. PSTCiti's 2026 Global Healthcare Conference Wednesday, December 2, 2026, at 11:00 a.m. EST / 8:00 a.m. PSTPiper Sandler 38th Annual Healthcare ConferenceThursday, December 3, 2026, at 11:30 a.m. EST / 8:30 a.m. PSTLive webcasts and replays will be accessible on the MiniM
- PRMiniMed to Announce Its Fiscal Year 2027 Second Quarter Financial ResultsNORTHRIDGE, Calif., Nov. 4, 2026 /PRNewswire/ -- MiniMed (NASDAQ:MMED), a global leader in diabetes technology, today announced that it expects to report financial results on Tuesday, November 24, 2026, for its second quarter of fiscal year 2027, which ended on Friday, October 30, 2026. A news release containing summary financial information is expected at approximately 3:45 a.m. Pacific Standard Time (PST) and will be available at https://news.minimed.com.A webcast discussing results is expected to be held at 5:30 a.m. PST, accessible at https://investors.minimed.com.A replay of the webcast and transcript of the prepared remar
- PRMiniMed Appoints Dr. David Segal as Chief Medical OfficerNORTHRIDGE, Calif., Nov. 3, 2026 /PRNewswire/ -- MiniMed (NASDAQ:MMED), a global leader in diabetes technology, today announced the appointment of David Segal, M.D., as Chief Medical Officer. Dr. Segal succeeds Robert Vigersky, M.D., who will transition to the role of Chief Medical Officer Emeritus ahead of his planned retirement at the end of 2027. Dr. Segal brings more than 20 years of experience in diabetes care, digital health and healthcare innovation, with a focus on using technology and data to improve patient outcomes and expand access to care."Dr. Segal brings deep clinical expertise and a passion for using technology
- INSIDEREVP Ch. Prod. & Tech Officer Dianaty Ali covered exercise/tax liability with 449 shares, decreasing direct ownership by 0.14% to 325,817 units (SEC Form 4) (tax liability)4 - MiniMed Group, Inc. (0002062583) (Issuer)
- SECSEC Form SCHEDULE 13G filed by MiniMed Group Inc.SCHEDULE 13G - MiniMed Group, Inc. (0002062583) (Subject)
- INSIDERSEC Form 4 filed by MiniMed Group Inc.4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDERSEC Form 4 filed by MiniMed Group Inc.4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDERSEC Form 4 filed by MiniMed Group Inc.4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDERSEC Form 4 filed by MiniMed Group Inc.4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDERSEC Form 4 filed by MiniMed Group Inc.4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDERSEC Form 4 filed by MiniMed Group Inc.4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDERSEC Form 3 filed by MiniMed Group Inc.3 - MiniMed Group, Inc. (0002062583) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by MiniMed Group Inc.SCHEDULE 13G/A - MiniMed Group, Inc. (0002062583) (Subject)
- INSIDERSEC Form 4 filed by MiniMed Group Inc.4 - MiniMed Group, Inc. (0002062583) (Issuer)
- SECSEC Form 8-K filed by MiniMed Group Inc.8-K - MiniMed Group, Inc. (0002062583) (Filer)
- PRMiniMed Completes Separation from MedtronicNORTHRIDGE, Calif., Oct. 15, 2026 /PRNewswire/ -- MiniMed (NASDAQ:MMED) today announced the completion of its separation from Medtronic plc ((", Medtronic", , NYSE:MDT), marking its first day as a fully independent company."Today marks the completion of our separation from Medtronic and a significant milestone for MiniMed," said Que Dallara, Chief Executive Officer of MiniMed. "We are grateful to Medtronic for its partnership and support in reaching this point. As an independent company, we have the freedom to make the decisions we believe are right for our business and the people we serve, and the responsibility to see those decisions through. Our focus now is to put that independence to wo
- PRMedtronic Completes Separation of MiniMed Group, Inc.GALWAY, Ireland, Oct. 15, 2026 /PRNewswire/ -- Medtronic plc ((Medtronic, NYSE:MDT) today announced the completion of its separation of MiniMed Group, Inc. ((MiniMed, NASDAQ:MMED)."I'm incredibly proud of what MiniMed and Medtronic have accomplished together and the meaningful difference we've made in the lives of people with diabetes," said Geoff Martha, Medtronic Chairman and Chief Executive Officer. "Today's separation marks an important milestone for both companies as each moves forward with a clear strategic focus. For Medtronic, that means putting the full weight of our organization behind advancing innovation and fueling growth across our Cardiovascular, Neuroscience and Surgical port
- PRMedtronic Announces Final Results of MiniMed Group, Inc. Exchange OfferGALWAY, Ireland, Oct. 14, 2026 /PRNewswire/ -- Medtronic plc ((Medtronic, NYSE:MDT) today announced the final results of its previously announced offer to exchange shares of common stock of MiniMed Group, Inc. ((MiniMed, NASDAQ:MMED) for outstanding Medtronic ordinary shares at an exchange ratio determined by a formula described in a registration statement filed by MiniMed on Form S-4 (Reg No. 333-298914). The exchange offer and withdrawal rights expired at 12:00 midnight, New York City time, at the end of the day on October 9, 2026.The exchange offer was oversubscribed, and Medtronic has elected to exchange all of its remaining interest in MiniMed (totaling 252,813,348 shares of MiniMed com
- INSIDERSEC Form 4 filed by MiniMed Group Inc.4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDERSEC Form 4 filed by MiniMed Group Inc.4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDERSEC Form 4 filed by MiniMed Group Inc.4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDERSEC Form 4 filed by MiniMed Group Inc.4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDERSEC Form 4 filed by MiniMed Group Inc.4 - MiniMed Group, Inc. (0002062583) (Issuer)
- ANALYSTRothschild & Co Redburn initiated coverage on MiniMed with a new price targetRothschild & Co Redburn initiated coverage of MiniMed with a rating of Buy and set a new price target of $30.00
MMED FAQ
10 questionsWhat is the latest news on MMED?
In the last 30 days Quantisnow tracked 28 wire items for MMED: 14 insider trades, 8 press releases and news items, 2 analyst ratings and 2 SEC filings. The most recent was published on November 6, 2026.What is MMED revenue?
MiniMed Group Inc. (MMED) reported $3.22B of revenue for the twelve months ended Jul 31, 2026. Revenue for fiscal 2026 was $3.10B.Is MMED profitable?
No. MiniMed Group Inc. reported a net loss of $309.00M for the twelve months ended Jul 31, 2026.How much cash and debt does MMED have?
MiniMed Group Inc. reported $207.00M in cash and cash equivalents on its most recent balance sheet in SEC filings.Where does MMED stock trade?
MiniMed Group Inc. (MMED) is listed on NASDAQ.What sector and industry is MMED in?
MiniMed Group Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did MiniMed Group Inc. go public?
MiniMed Group Inc. (MMED) completed its IPO in 2026.What are analysts saying about MMED?
MiniMed Group Inc. has had 8 recent analyst actions on file. The most recent action was from Rothschild & Co Redburn: Buy with a $30.00 price target on 2026-10-13. Recent price targets range from $20.00 to $30.00.What companies are similar to MMED?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare MMED side-by-side with any of them on Quantisnow.How can I track MMED on Quantisnow?
Quantisnow aggregates MiniMed Group Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MMED to receive live email and push alerts on every new disclosure.